Pharma Reviews: Five reasons why Morgan Stanley has turned bullish on Sun Pharma

The brokerage firm said Sun Pharma was its top pick in its Indian healthcare coverage and sees 27 per cent upside in the stock. The brokerage firm ...
Read more: Five reasons why Morgan Stanley has turned bullish on Sun Pharma